Profiel
Michael F. Bigham, oprichter van Magellan Diagnostics, Inc., is een zakenman die aan het roer heeft gestaan van 6 verschillende bedrijven en momenteel Uitvoerend Voorzitter is bij Paratek Pharmaceuticals, Inc. Hij zit ook in de raad van bestuur van Adamas Pharmaceuticals, Inc., Inmediata Health Group (voormalig voorzitter), inMediata Corp. en Frazier Lifesciences Acquisition Corp. In het verleden bekleedde hij de functie van Chief Financial Officer & Executive VP-Operations bij Gilead Sciences, Inc., Executive Partner bij Abingworth Management Ltd. en Partner bij Abingworth LLP (een dochteronderneming van Abingworth Management Ltd.), Voorzitter & Chief Executive Officer van Paratek Pharmaceuticals, Inc, Voorzitter van Magellan Diagnostics, Inc., Bestuurder van Avila Therapeutics, Inc., President & Chief Executive Officer van Coulter Pharmaceuticals, Inc. en Partner & Co-Head-Healthcare Investment Banking bij Hambrecht & Quist Group, Inc. Hij behaalde een bachelor diploma aan de Universiteit van Virginia en een MBA aan de Stanford Universiteit.
Actieve functies van Michael Bigham
| Bedrijven | Functie | Begin |
|---|---|---|
TeneoBio, Inc.
TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Directeur/Bestuurslid | - |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Directeur/Bestuurslid | - |
Eerdere bekende functies van Michael Bigham
| Bedrijven | Functie | Einde |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Algemeen Directeur | 25-06-2019 |
| ADAMAS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 24-11-2021 |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Corporate Officer/Principal | 01-11-2015 |
| SUPERNUS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 23-12-2013 |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Algemeen Directeur | 01-01-2012 |
Opleiding van Michael Bigham
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 27 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Hambrecht & Quist Group, Inc.
Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Operates as a holding investment bank and provides securities brokerage services | Finance |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Provides real time in-vivo imaging services | Health Technology |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Avedro, Inc.
Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Abingworth Management Ltd.
Abingworth Management Ltd. Investment ManagersFinance Operates as an investment firm | Finance |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Magellan Diagnostics, Inc.
Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Health Technology |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Valeritas, Inc.
Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Inmediata Health Group
Inmediata Health Group Electronic Production EquipmentElectronic Technology Offers electronic solutions for enhancing the efficiency and the quality of health and dental care | Electronic Technology |
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
inMediata Corp.
inMediata Corp. Regional BanksFinance Provides payment reconciliation solutions | Finance |
TeneoBio, Inc.
TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Health Technology |
Magellan Biosciences, Inc.
Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for point-of-care systems, clinical laboratory instruments and analytical laboratory | Health Technology |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Technology Services |
Frazier Lifesciences Acquisition Corp.
Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
















